Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573605
Core Stability Training Combined With Plyometric Exercises on Vertical Jump Performance:Alva's College of PhysiotherapyCompletedNot Applicable
NCT07573605Completed
Not Applicable
Core Stability Training Combined With Plyometric Exercises on Vertical Jump Perf...Alva's College of Physiot...
NCT07573072
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico RizzoliCompleted
NCT07573072Completed
—
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico Rizzo...
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07571993
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlinico San Matteo di PaviaRecruiting
NCT07571993Recruiting
—
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlin...
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07572448
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of SafetyUludag UniversityNot Yet Recruiting
NCT07572448Not Yet Recruiting
—
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sens...Uludag University
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07572760
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.Hospital General Universitario Dr. Balmis de AlicanteRecruitingNot Applicable
NCT07572760Recruiting
Not Applicable
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.Hospital General Universi...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 42 (10%)
Phase 22 (10%)